Copper-64 TP3805
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Copper-64 TP3805, covering 2025-03-27 to 2025-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA [NA]